U.S. stocks were higher, with the Dow Jones index gaining over 150 points on Thursday.
Shares of Accenture plc ACN rose sharply in today's session after the company reported better-than-expected first-quarter financial results and raised FY25 revenue growth outlook.
On Thursday, Accenture reported first-quarter fiscal 2025 sales of $17.69 billion compared with the analyst consensus estimate of $17.12 billion, up 9% year-over-year in U.S. dollars and 5% in local currency.
Accenture shares jumped 7% to $372.09 on Wednesday.
Here are some other big stocks recording gains in today's session.
- Omeros Corporation OMER shares jumped 68% to $12.55 after the company's Narsoplimab met pivotal trial primary endpoint.
- Soho House & Co Inc. SHCO gained 54% to $7.57 after the company received a $9.00 per share acquisition offer from a consortium backed by Executive Chairman Ron Burkle and Yucaipa. The board has formed a special committee to evaluate the proposal.
- Mesoblast Limited MESO rose 35% to $16.55. On Wednesday, the FDA approved Mesoblast's Ryoncil (remestemcel-L) as the first mesenchymal stromal cell (MSC) therapy in the U.S.
- Microvast Holdings, Inc. MVST gained 21.7% to $1.3990.
- Sable Offshore Corp. SOC surged 20.3% to $23.63.
- Prothena Corporation plc PRTA gained 17.8% to $14.09 after the Phase IIb Prasinezumab study showed potential in early Parkinson’s disease.
- Darden Restaurants, Inc. DRI rose 14.3% to $182.79 after the company reported better-than-expected second-quarter EPS and issued better-than-expected FY25 revenue outlook.
- Innodata Inc. INOD gained 14.2% to $39.09. Wedbush analyst Daniel Ives initiated coverage on Innodata with an Outperform rating and announced a price target of $48.
- Valneva SE VALN gained 10.1% to $4.16. Valneva expanded Chikungunya vaccine access in Asia through partnership with Serum Institute.
- Tripadvisor, Inc. TRIP rose 8.8% to $14.10. Tripadvisor and Liberty TripAdvisor announced a planned merger.
- Nordstrom, Inc. JWN shares gained 4.8% to $23.98.
- CarMax, Inc. KMX shares rose 4.5% to $85.08 after the company reported better-than-expected quarterly earnings and sales.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.